9. Accounts payable and accrued expenses (Details Narrative)	3 Months Ended	12 Months Ended
	May 31, 2026	Feb. 28, 2026
European Cardiac Supplier [Member] \| Trade Accounts Payable Total [Member]
Product Information [Line Items]
Concentration Risk, Percentage	45.00%	53.00%

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.